Results 61 to 70 of about 18,913,418 (345)

Investigation protocol: Acromegaly and its investigation [PDF]

open access: yesClinical Endocrinology, 1999
The diagnosis of acromegalyAcromegaly is an uncommon but serious disease due to anexcessive production of growth hormone (GH), usually from apituitary tumour. Although it has an insidious onset, onceclinically suspected its diagnosis is not usually difficult.
Duncan E., Wass J.A.H.
openaire   +6 more sources

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma

open access: yesHaematologica, 2018
Mogamulizumab, a humanized defucosylated anti-C-C chemokine receptor 4 monoclonal antibody, has been approved in Japan for the treatment of C-C chemokine receptor 4-positive adult T-cell leukemia/lymphoma (ATL). This phase II study evaluated efficacy and
A. Phillips   +18 more
semanticscholar   +1 more source

Incidence of herpes zoster and postherpetic neuralgia in Italian adults aged ≥50 years: A prospective study

open access: yesPreventive Medicine Reports, 2019
Herpes zoster (HZ) mainly affects older adults and immunocompromised individuals and is usually characterized by a unilateral painful skin rash. Its most common complication, postherpetic neuralgia (PHN), may cause chronic debilitating pain lasting for ...
Andrea Salvetti   +14 more
doaj   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment?

open access: yesPLoS Biology, 2018
Human protection policies require favorable risk–benefit judgments prior to launch of clinical trials. For phase I and II trials, evidence for such judgment often stems from preclinical efficacy studies (PCESs). We undertook a systematic investigation of
S. Wieschowski   +5 more
semanticscholar   +1 more source

Code Base Investigator v1.2.0

open access: yes
<p>Although a minor release, Code Base Investigator v1.2.0 includes a few significant changes.</p> <blockquote> <p><strong>IMPORTANT</strong><br>In previous releases of Code Base Investigator, the main script was
Douglas Jacobsen   +2 more
core   +1 more source

[EB 2010, Young Investigator]

open access: yes, 2010
[Title supplied by cataloger]Young Investigator Adrian Salic at Experimental Biology ...
Unknown
core   +4 more sources

THE OBSTRUCTION OF THE ADMINISTRATION OF JUSTICE AND PRELIMINARY INVESTIGATION: PROBLEMS OF THE OBJECT AND THE OBJECTIVE SIDE

open access: yesПравоприменение, 2018
The subject. The article is devoted to the investigation of the main direct object and the circle of victims are subjected of harm by criminal acts stipulated by pts. 1, 2 of art.
A. V. Boyarskaya
doaj   +1 more source

Clinical trial insurance in Serbia [PDF]

open access: yesHospital Pharmacology, 2015
Prior the commencement of the clinical trial in Serbia the Sponsor is obliged to provide the insurance policy covering the patient's bodily injury and damaged health caused by the clinical trial. According to provisions of Serbian Insurance law insurance
Žagar Zlatko A.
doaj   +1 more source

Home - About - Disclaimer - Privacy